iOS app Android app

Astrazeneca

Wrong Questions, Wrong People

Michael Hodin | Posted 08.02.2014 | Business
Michael Hodin

Pfizer's move to acquire British-based pharma company AstraZeneca has proven that too many in the political world have not a clue how markets work, how innovation takes place, or how economic growth is achieved.

Pfizer Is Abandoning Controversial Plan

Reuters | Posted 07.26.2014 | Business

* U.S. drugmaker abandons takeover attempt after rejection * Move had been widely anticipated given May 26 deadline * Pf...

AstraZeneca Rejects Pfizer's Sweetened Takeover Bid

AP | GREGORY KATZ and LINDA A. JOHNSON | Posted 07.18.2014 | Business

LONDON (AP) — The board of AstraZeneca on Monday rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that cause...

Pfizer Really Wants To Take Over AstraZeneca

Reuters | Ben Hirschler | Posted 06.27.2014 | Business

* Pfizer sought further talks April 26 after Jan rebuff * AstraZeneca declined to engage on earlier two occasions * Late...

Drugmaker To End Controversial Practice

Reuters | Posted 02.16.2014 | Business

* GSK scrapping doctor payments for speaking engagements * Ending sales reps' targets globally following U.S. move * Com...

Workers of the World Unite -- With Shareholders

Leo W. Gerard | Posted 07.21.2012 | Business
Leo W. Gerard

In the wake of Wall Street recklessness that caused economic collapse, Congress gave shareholders and citizens Dodd-Frank to help them constrain self-dealing corporate executives. The 99% Coalition and shareholders are working with those tools even as Republicans vow to take them away.

Shareholder Pay Revolt Drives Major CEO To Resign

AP | Posted 05.08.2012 | Business

LONDON -- The chief executive of Aviva, Britain's largest insurer, has resigned following a shareholder revolt over executive pay, the company said Tu...

British Drug Giant To Slash More Than 1,000 U.S. Jobs

Posted 12.07.2011 | Business

LONDON (Reuters) - AstraZeneca is cutting nearly a quarter of its U.S. sales force in a second wave of redundancies in as many months as it seeks ...

SAC Capital Faces Insider Trading Probe On Takeover Of MedImmune

Posted 08.01.2011 | Business

SAC Capital Advisors LP faces an insider trading probe from the U.S. Securities and Exchange Commission related to the $15 billion takeover of bio...

Drug Maker And $520 Million: Settlement Reached After Illegal Marketing Claim

AP | PETE YOST | Posted 05.25.2011 | Business

WASHINGTON — The federal government on Tuesday reached a $520 million settlement with pharmaceutical manufacturer AstraZeneca, resolving allegat...

Sam Stein

Pharma CEO: We Will Fight House Health Care Bill

HuffingtonPost.com | Sam Stein | Posted 05.25.2011 | Politics

The CEO of one of the biggest pharmaceutical companies in the country said on Friday that he and others in the industry would switch their support for...

Swine Flu Vaccine Delivery Falls Short; Less Than Half Of Expected Doses Have Been Delivered

Wall Street Journal | BETSY MCKAY and JENNIFER CORBETT DOOREN | Posted 11.17.2011 | Healthy Living

Less than half of the swine-flu vaccine expected to be shipped to doctors, hospitals and clinics in the U.S. this month has been shipped so far. The d...

Most Depressing Ad of 2009

Anne Z. Boxer | Posted 11.17.2011 | Healthy Living
Anne Z. Boxer

The current TV ad for SeroquelXR is so depressing it is hard to watch. One full viewing was enough -- after that it was zapped by the remote after the first treacly musical note.

India: Wal-Mart's Drug Connection

Al Norman | Posted 05.25.2011 | Business
Al Norman

Most Americans have no idea that the drugs they are buying at Wal-Mart are produced in India, made by companies that are copying another company's products.

Top European Drugmakers Back Stem Cell Testing

Reuters | Ben Hirschler | Posted 05.25.2011 | Business

Three of Europe's top drugmakers have backed a new public-private scheme to use stem cells for safety testing of experimental medicines, signaling "bi...